ORIC Pharmaceuticals, Inc.
ORIC Pharmaceuticals, Inc.
ORIC
Valuace
70
Růst
30
Zdraví
75
Cena
$ 12.37
Dnes
+0.60 (5.21%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
1.2B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
0%
ROA
0%
PE
-7
PS
0
Cena 1R
4-15
⌀ Cena
9.63
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
24-02-2026
Poslední dividenda

Profil

ORIC Pharmaceuticals, Inc., biofarmaceutická společnost v klinickém stadiu, objevuje a vyvíjí terapie pro léčbu rakoviny ve Spojených státech. Mezi jeho klinické stádium patří ORIC-533, perorálně biologicky dostupný inhibitor CD73 vyvíjený pro rezistenci k léčebným režimům založeným na chemoterapii a imunoterapii; ORIC-944, allosterický inhibitor polykombového represivního komplexu 2 pro karcinom prostaty; a ORIC-114, perorálně biologicky dostupný ireverzibilní inhibitor mozku určený k selektivnímu cílení receptoru epidermálního růstového faktoru a receptoru lidského epidermálního růstového faktoru 2 s vysokou účinností vůči mutačním mutacím exon 220. Společnost také vyvíjí mnohočetné přípravky pro přesnou fázi objevů zaměřené na jiné mechanismy rezistence vůči nádorovým onemocněním. Má licenční smlouvu s firmou Voronoi Inc. a licenční smlouvu s Mirati Therapeutics, Inc. Společnost byla založena v roce 2014 a sídlí v jižním San Francisku v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
122
Založení
2020-04-24
Adresa
240 East Grand Avenue
CEO
Jacob M. Chacko

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 20252024202320222021202020192018
Total Revenues0.000.000.000.000.000.000.000.000.00
Cost of Revenues320.001,220.001,107.001,032.000.000.000.000.000.00
Gross Profit-320.00-1,220.00-1,107.00-1,032.000.000.000.000.000.00
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues0.000.000.000.000.000.000.000.001,538.000.00
Cost of Revenues320.000.000.000.00304.000.000.00261.00263.00257.00
Gross Profit-320.000.000.000.00-304.000.000.00-261.001,275.00-257.00
Operating Income TTM 20252024202320222021202020192018
R&D Expenses0.000.000.0085,172.0061,680.0056,858.0035,921.0022,844.0019,026.00
Selling General & Admin Expenses0.000.000.0025,608.0025,087.0022,013.0013,422.005,725.003,345.00
Depreciation & Amortization1,220.001,220.001,107.001,032.0010,000.00897.0049,686.001,028.00903.00
Total Operating Expenses142,684.00141,784.00141,788.00110,780.0086,767.0078,871.0049,343.0028,569.0022,371.00
Operating Income-143,004.00-143,004.00-142,895.00-110,780.00-91,767.00-78,871.00-74,186.00-28,569.00-22,371.00
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.000.000.000.000.000.000.000.0024,481.0022,388.00
Selling General & Admin Expenses0.000.000.000.000.000.000.000.006,684.006,294.00
Depreciation & Amortization320.00288.00310.00302.00304.00270.00272.00261.00263.00257.00
Total Operating Expenses34,231.0036,671.0039,064.0032,718.0039,266.0038,318.0036,017.0028,729.0031,165.0028,682.00
Operating Income-34,551.00-36,671.00-39,064.00-32,718.00-39,570.00-38,318.00-36,017.00-28,990.00-31,428.00-28,682.00
Net Income TTM 20252024202320222021202020192018
Interest Income0.000.000.0010,083.002,645.00141.00306.001,397.00775.00
Interest Expense0.000.000.000.002,645.000.000.000.00-1,008.00
Other Expense13,536.0013,536.0015,048.0010,083.002,645.00156.00483.001,686.00233.00
IBT-129,468.00-129,468.00-127,847.00-100,697.00-89,122.00-78,715.00-73,703.00-26,883.00-21,363.00
Income Tax Expense0.000.000.000.002,355.00-1,038.0023,567.00-1,397.00-1,008.00
Net Income-129,468.00-129,468.00-127,847.00-100,697.00-91,477.00-77,677.00-97,270.00-25,486.00-21,363.00
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income0.000.000.000.000.000.004,054.003,979.003,098.003,204.00
Interest Expense0.000.000.000.000.000.000.000.001,986.000.00
Other Expense4,046.004,084.002,709.002,697.003,263.003,752.004,054.003,979.003,098.003,204.00
IBT-30,505.00-32,587.00-36,355.00-30,021.00-36,307.00-34,566.00-31,963.00-25,011.00-28,330.00-25,478.00
Income Tax Expense0.000.000.000.000.000.000.000.002,243.00-257.00
Net Income-30,505.00-32,587.00-36,355.00-30,021.00-36,307.00-34,566.00-31,963.00-25,011.00-28,330.00-25,478.00
Per Share Data TTM 20252024202320222021202020192018
EPS$0.00$0.00$0.00$-1.96$-2.31$-2.05$-4.43$-1.33$-1.12
EPS Diluted$0.00$0.00$0.00$-1.96$-2.31$-2.05$-4.43$-1.33$-1.12
Shares Outstanding87,793.8087,793.8069,727.9451,450.0039,655.2637,954.2821,942.4819,141.2119,141.21
Diluted Shares Outstanding87,793.8087,793.8069,727.9451,450.8539,655.2637,954.2821,942.4819,141.2119,141.21
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.49$-0.44
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.49$-0.44
Shares Outstanding87,793.8098,953.3378,126.0071,040.0070,652.0170,542.6870,348.4167,349.5557,464.0457,402.23
Diluted Shares Outstanding87,793.8098,953.3378,126.2671,040.5870,652.0170,542.6870,348.4167,349.5557,464.0457,402.23
Current Assets TTM 2024202320222021202020192018
Cash And Equivalents49,831.0059,406.0023,384.0066,840.00226,006.0078,446.0089,159.0042,636.00
Short Term Investments236,575.00196,554.00184,803.00139,432.0010,973.00215,154.000.000.00
Total Cash & ST Investments286,406.00255,960.00208,187.00206,272.00236,979.00293,600.0089,159.0042,636.00
Accounts Receivable0.000.000.000.000.000.000.000.00
Inventory0.000.000.000.000.000.000.000.00
Other Current Assets8,193.006,290.004,410.004,185.003,543.003,097.00840.001,088.00
Total Current Assets294,599.00262,250.00212,597.00210,457.00240,522.00296,697.0089,999.0043,724.00
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents49,668.0075,864.0049,334.0059,406.0044,230.0049,831.0056,360.0023,384.0026,238.00103,683.00
Short Term Investments237,472.00206,649.00154,389.00196,554.00228,139.00236,575.00260,418.00184,803.00201,058.00160,476.00
Total Cash & ST Investments287,140.00282,513.00203,723.00255,960.00272,369.00286,406.00316,778.00208,187.00227,296.00264,159.00
Accounts Receivable0.000.000.000.000.000.000.000.000.000.00
Inventory0.000.000.000.000.000.000.000.000.000.00
Other Current Assets8,454.008,611.007,710.006,290.007,059.008,193.007,305.004,410.004,940.004,199.00
Total Current Assets295,594.00291,124.00211,433.00262,250.00279,428.00294,599.00324,083.00212,597.00232,236.00268,358.00
Long-Term Assets TTM 2024202320222021202020192018
Net Property, Plant & Equipment2,878.002,924.0012,006.003,253.002,413.001,981.002,241.002,514.00
Goodwill0.000.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.000.000.00
Long-Term Investments22,617.000.0026,852.0021,951.0043,386.000.000.000.00
Other Long-Term Assets8,812.008,968.00552.0011,517.0012,321.00319.001,853.00496.00
Total Long-Term Assets34,307.0011,892.0039,410.0036,721.0058,120.002,300.004,094.003,010.00
Total Assets328,906.00274,142.00252,007.00247,178.00298,642.00298,997.0094,093.0046,734.00
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment2,559.002,762.003,021.002,924.003,091.002,878.002,801.0012,006.003,062.003,250.00
Goodwill0.000.000.000.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.000.000.000.000.00
Long-Term Investments125,908.0045,216.0020,039.000.009,998.0022,126.0014,694.0027,343.0028,867.009,575.00
Other Long-Term Assets7,131.007,755.008,365.008,968.009,553.009,303.009,208.0061.0010,170.0010,633.00
Total Long-Term Assets135,598.0055,733.0031,425.0011,892.0022,642.0034,307.0026,703.0042,089.0042,099.0023,458.00
Total Assets431,192.00346,857.00242,858.00274,142.00302,070.00328,906.00350,786.00254,686.00274,335.00291,816.00
Current Liabilities TTM 2024202320222021202020192018
Accounts Payable2,309.001,548.00944.001,320.001,886.00757.00152.00446.00
Short-Term Debt2,770.003,183.002,752.002,659.001,926.000.000.000.00
Other Current Liabilities14,460.0020,115.0016,762.0011,409.0011,339.008,245.005,202.002,150.00
Current Liabilities19,539.0024,846.0020,458.0015,388.0015,151.009,002.005,354.002,596.00
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable2,900.003,130.005,160.001,548.004,249.002,309.002,988.00944.003,736.003,191.00
Short-Term Debt3,301.003,273.003,213.003,183.003,121.002,770.002,775.002,752.002,728.002,704.00
Other Current Liabilities13,978.0011,647.009,244.0020,115.0013,878.0014,460.009,447.0016,762.0012,480.008,639.00
Current Liabilities20,179.0018,050.0017,617.0024,846.0021,248.0019,539.0015,210.0020,458.0018,944.0014,534.00
Long-Term Liabilities TTM 2024202320222021202020192018
Long-Term Debt0.000.000.000.000.000.000.000.00
Capital Leases2,770.003,183.002,752.002,659.001,926.000.000.000.00
Def. Tax Liability0.000.000.000.000.000.000.000.00
Total Liabilities26,506.0031,020.0027,919.0024,827.0025,666.009,221.006,119.00111,160.00
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt0.000.000.000.000.000.000.000.000.000.00
Capital Leases3,301.003,273.003,213.003,183.003,121.002,770.002,775.007,461.002,728.002,704.00
Def. Tax Liability0.000.000.000.000.000.000.002,679.000.000.00
Total Liabilities24,273.0022,862.0023,120.0031,020.0028,076.0026,506.0022,141.0030,598.0026,921.0023,017.00
Total Common Equity TTM 2024202320222021202020192018
Common Stock7.007.006.005.004.004.002.000.00
Retained Earnings-491,901.00-562,774.00-434,927.00-334,230.00-245,108.00-166,393.00-92,690.00-65,807.00
Comprehensive Income-256.00379.00258.00-1,291.00-103.00-31.000.00-2,578.00
Total Common Equity302,400.00243,122.00224,088.00222,351.00272,976.00289,776.0087,974.00-64,426.00
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock11.009.007.007.007.007.007.006.006.006.00
Retained Earnings-661,737.00-629,150.00-592,795.00-562,774.00-526,467.00-491,901.00-459,938.00-434,927.00-406,597.00-381,119.00
Comprehensive Income615.00187.00209.00379.00722.00-256.00-162.00258.00-369.00-567.00
Total Common Equity406,919.00323,995.00219,738.00243,122.00273,994.00302,400.00328,645.00224,088.00247,414.00268,799.00
Other TTM 2024202320222021202020192018
Total Debt2,770.003,183.0010,213.002,659.001,926.000.000.000.00
Book Value302,400.00243,122.00224,088.00222,351.00272,976.00289,776.0087,974.00-64,426.00
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.000.000.000.000.000.000.000.000.000.00
Book Value406,919.00323,995.00219,738.00243,122.00273,994.00302,400.00328,645.00224,088.00247,414.00268,799.00
Cash Flow From Operating Activities TTM 20252024202320222021202020192018
Net Income-110,782.00-129,468.00-127,847.00-100,697.00-89,122.00-78,715.00-73,703.00-26,883.00-21,363.00
Depreciation & Amortization1,053.001,220.001,107.001,032.00966.00897.00970.001,028.00903.00
Stock-Based Compensation17,741.000.0020,213.0015,226.0014,460.0012,853.005,278.001,094.00469.00
Change Working Capital817.00-5,459.001,968.004,898.00-445.004,073.002,045.001,220.00-707.00
Change In Accounts Receivable0.000.000.000.000.000.000.000.000.00
Change In Accounts Payable2,932.00-7,246.001,825.003,278.00-1,475.002,931.004,303.00986.00-410.00
Change In Inventories0.000.000.000.000.000.000.000.000.00
Other Non-cash Items7,498.0020,340.00-8,103.00-6,147.00-1,002.001,351.0019,843.008.0015.00
Cash from Operations-100,121.000.000.00-85,688.00-75,143.00-59,541.00-45,268.00-23,533.00-20,683.00
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-30,505.00-32,587.00-36,355.00-30,021.00-36,307.00-34,566.00-31,963.00-25,011.00-28,330.00-25,478.00
Depreciation & Amortization320.00288.00310.00302.00304.00270.00272.00261.00263.00257.00
Stock-Based Compensation6,278.005,631.006,574.000.000.005,056.004,996.004,958.003,923.003,864.00
Change Working Capital1,664.002,143.00-780.00-8,486.004,380.002,389.003,366.00-8,167.001,984.003,634.00
Change In Accounts Receivable0.000.000.000.000.000.000.000.000.000.00
Change In Accounts Payable-448.000.000.00-7,911.003,026.00757.003,800.00-5,758.00979.003,911.00
Change In Inventories0.000.000.000.000.000.000.000.000.000.00
Other Non-cash Items-240.00-587.00-591.005,430.003,569.00-1,946.00-2,296.00-2,395.001,133.00-1,922.00
Cash from Operations0.000.000.000.000.000.000.000.00-24,497.00-19,645.00
Cash Flow From Investing Activities TTM 20252024202320222021202020192018
Capital Expenditure-685.00-712.00-1,188.00-849.00-2,078.00-939.00-667.00-768.00-525.00
Acquisitions36.730.000.000.002,078.001,375.000.000.000.00
Investments-303,241.00-399,819.00-251,920.00-239,244.00-238,124.00-69,626.00-225,485.000.000.00
Sales of Investment223,470.00252,500.00275,245.00196,690.00130,954.00229,000.0010,000.000.000.00
Other Investing Activities-254.730.000.000.00-2,078.00-1,375.00193.000.0017.00
Cash from Investing-80,456.000.000.00-43,403.00-109,248.00158,435.00-215,959.00-768.00-508.00
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-450.00-35.00-63.00-387.00-219.00551.00-333.00-218.00-57.00-77.00
Acquisitions0.000.000.000.000.000.000.000.00-21.0257.75
Investments-45,289.00-165,500.00-124,367.00-64,663.00-34,626.00-54,012.00-48,887.00-114,395.00-28,970.00-110,989.00
Sales of Investment62,500.0055,000.0047,500.0087,500.0077,500.0077,500.0067,500.0052,745.0049,990.0053,235.00
Other Investing Activities0.000.000.000.000.000.000.000.0021.02-57.75
Cash from Investing0.000.000.000.000.000.000.000.0020,963.00-57,831.00
Cash Flow From Financing Activities TTM 20252024202320222021202020192018
Debt Repaid0.000.000.000.000.000.000.000.000.00
Debt Issued66.003,183.00-7,030.007,554.00733.001,926.000.000.000.00
Issuance of Common Stock126,725.000.000.0085,000.0025,000.0050,000.00271,308.000.000.00
Repurchase of Common Stock2,350,359.000.000.000.00545.000.000.000.000.00
Dividends Paid0.000.000.000.000.000.000.000.000.00
Other Financing Activities316.000.000.00658.00-320.00-866.00-20,794.0070,824.0038,008.00
Cash from Financing126,725.000.000.0085,658.0025,225.0049,134.00250,514.0070,824.0038,008.00
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.000.000.000.000.000.000.000.000.000.00
Debt Issued3,301.0028.0060.0030.0062.00351.00-5.00-7,438.007,485.0024.00
Issuance of Common Stock0.000.000.000.000.000.000.000.00226.00-226.00
Repurchase of Common Stock0.000.000.000.000.000.000.000.000.000.00
Dividends Paid0.000.000.000.000.000.000.000.000.000.00
Other Financing Activities0.000.000.000.000.000.000.000.00227.0031.00
Cash from Financing0.000.000.000.000.000.000.000.00680.0031.00
Cash position TTM 20252024202320222021202020192018
Net Change in Cash-53,852.00-13,737.0036,022.00-43,433.00-159,166.00148,028.00-10,713.0046,523.0016,817.00
Closing Cash Balance49,831.0046,160.0059,897.0023,875.0067,308.00226,474.0078,446.0089,159.0042,636.00
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash-3,999.00-26,196.0026,530.00-10,072.0015,176.00-5,601.00-6,529.0032,976.00-2,854.00-77,445.00
Closing Cash Balance46,160.0050,159.0076,355.0049,334.0059,406.0044,721.0049,831.0056,360.0023,384.0026,729.00
Free Cash Flow TTM 20252024202320222021202020192018
Free Cash Flow-100,806.00-114,079.00-113,850.00-86,537.00-77,221.00-60,480.00-45,935.00-24,301.00-21,208.00
Real Free Cash Flow-118,547.00-114,079.00-134,063.00-101,763.00-91,681.00-73,333.00-51,213.00-25,395.00-21,677.00
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-22,870.00-25,147.00-30,905.00-33,162.00-28,273.00-29,215.00-25,958.00-30,572.00-24,554.00-19,722.00
Real Free Cash Flow-29,148.00-30,778.00-37,479.00-33,162.00-28,273.00-34,271.00-30,954.00-35,530.00-28,477.00-23,586.00
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-6.9-7.2-1.4
P/S0164.49.4
P/B2.21.85.2
P/FCF-6.9-8.1-1.5
Market cap$1.2$6.0
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %0.6 %0 %
Debt to Income-2.5 %-1.9 %0 %
Debt to Free cash flow-2.5 %-2194.8 %0 %
Interest expense percentage0 %-0 %44.7 %
Current ratio14.6 16.3 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-31.8 %-28.6 %0 %
ROA-30 %-28.6 %0 %
CapEx to Revenue0 %5.9 %0 %
RaD to Revenue0 %2054.6 %0 %
ROEM0.0 1026.9

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin0 %5.8 %68.7 %
Operating margin0 %-2609.5 %35.5 %
Net margin0 %-2351.2 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding87.8 mil 47.2 mil
Employee count0.1 tis 0.1 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader